Break message

Slovenská verzia

Notice of first launch, interruption or termination of supply of a human drug

Date	Holder	Code	Drug	Date from	Subject ▲

31.5.2019	Sandoz Pharmaceuticals d.d. (SAN-SLO-1)	36466	Vinorelbin "Ebewe" 10 mg/ ml infúzny koncentrát (con inf 1x1 ml/10 mg (liek.inj.skl.))	5.6.2019	Z
31.5.2019	Mylan IRE Healthcare Limited (MYR)	12514	Breakyl 200 mikrogramov (flm buc 28x200 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))	20.5.2019	Z
6.5.2019	Bayer AG (BAY)	34633	Levitra 10 mg filmom obalené tablety (tbl flm 4x10 mg (blis.PP/Al))	1.8.2019	Z
15.4.2019	medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)	78211	Irinotecan medac 20 mg/ml (con inf 1x5 ml/100 mg (liek.inj.skl.hnedá))	1.9.2019	Z
19.8.2019	Glenmark Pharmaceuticals s.r.o. (GLM-CZ)	4535B	Aripiprazol Glenmark 15 mg tablety (tbl 28x1x15 mg (blis.OPA/Al/PVC/Al-perfor.))	30.9.2019	Z
19.8.2019	sanofi-aventis Slovakia s.r.o. (SAV-SK-1)	94473	Pharmaton Geriavit (cps mol 30 (fľ.skl.hnedá))	3.6.2019	Z
22.7.2019	Glenmark Pharmaceuticals s.r.o. (GLM-CZ)	86798	ULPRIX 40 mg (tbl ent 100x40 mg (blis.OPA/Al/PVC/Al))	30.9.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	80020	Irbesartan Actavis 300 mg (tbl flm 60x300 mg (fľ.HDPE))	15.12.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	80016	Irbesartan Actavis 300 mg (tbl flm 84x300 mg (blis.PVC/PVDC/Al))	1.10.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	80019	Irbesartan Actavis 300 mg (tbl flm 30x300 mg (fľ.HDPE))	25.4.2019	Z
1.7.2019	Fresenius Kabi s.r.o. (FRK-CZ-3)	86626	Irinotecan Fresenius 20 mg/ml infúzny koncentrát (con inf 1x2 ml/40 mg (liek.skl.hnedá))	1.7.2019	Z
1.7.2019	Gedeon Richter Plc. (GDN)	0257B	Bemfola 450 IU/0,75 ml injekčný roztok v naplnenom pere (sol inj 1x0,75 ml/450 IU (náplň skl.v napl.pere + 1 ihla))	1.9.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	80003	Irbesartan Actavis 150 mg (tbl flm 84x150 mg (blis.PVC/PVDC/Al))	24.1.2019	Z
31.5.2019	Mylan IRE Healthcare Limited (MYR)	02492	Breakyl 200 mikrogramov (flm buc 10x200 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))	20.5.2019	Z
17.4.2019	TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)	93260	HERPESIN 250 (plv inf 10x250 mg (liek.skl.))	1.8.2019	Z

« Previous | Next »

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market

From
To